Ana Silvia Sartori Barraviera Seabra Ferreira, Cassiana Mendes Bertoncelo Fontes, Lehana Thabane, Carolina Russo Simon, João Pedro Pereira Caetano de Lima, Jean Carlos Possidônio da Silva, Benedito Barraviera, Raul Borges Guimarães, Pasqual Barretti, Rui Seabra Ferreira
{"title":"Telemedicine for COVID-19 management in Brazil: outcomes and health system implications from a prospective cohort study.","authors":"Ana Silvia Sartori Barraviera Seabra Ferreira, Cassiana Mendes Bertoncelo Fontes, Lehana Thabane, Carolina Russo Simon, João Pedro Pereira Caetano de Lima, Jean Carlos Possidônio da Silva, Benedito Barraviera, Raul Borges Guimarães, Pasqual Barretti, Rui Seabra Ferreira","doi":"10.1590/1678-9199-JVATITD-2025-0030","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The COVID-19 pandemic exposed vulnerabilities in traditional disease surveillance systems, particularly in data reporting and contact tracing. Telemedicine emerged as a promising approach to expand remote access to healthcare. This study aimed to evaluate a newly implemented telemedicine system designed to manage patients with COVID-19, reduce hospital overload, enable early case detection and isolation, ensure rapid response to clinical deterioration, simplify medical records, and provide ongoing patient support.</p><p><strong>Methods: </strong>A prospective cohort study was conducted using the E-care telemedicine system to assist adult patients presenting with COVID-19 symptoms at a Brazilian university between June 2021 and June 2024.</p><p><strong>Results: </strong>The E-care system delivered care to 6,129 patients, predominantly female, white university students. Physicians attended over 80% (4,903/6,129) of patients and prescribed medications to nearly 28% (1,411/5,041). Medical certificates for time off work were issued to 43% (2,635/6,129) of participants. COVID-19 tests were recommended for approximately 24% of patients, with a positivity rate above 81% among those who returned results. Only 66 patients (1.2%) required in-person care, and no COVID-19-related deaths were reported. Patient satisfaction was high, with 96% (5,584/6,129) expressing satisfaction or high satisfaction with the service.</p><p><strong>Conclusions: </strong>This study provides robust evidence supporting the successful implementation of a telemedicine system for managing COVID-19 cases. The large number of users highlights an unmet demand for virtual healthcare. Telemedicine was rapidly adopted, achieved high patient satisfaction, and contributed to reducing hospital burden, promoting early detection, and minimizing in-person consultations. These findings reinforce the value of telemedicine as an essential tool for health systems and policymakers to strengthen care delivery beyond the pandemic.</p>","PeriodicalId":17565,"journal":{"name":"Journal of Venomous Animals and Toxins Including Tropical Diseases","volume":"31 ","pages":"e20250030"},"PeriodicalIF":1.8000,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12707318/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Venomous Animals and Toxins Including Tropical Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1590/1678-9199-JVATITD-2025-0030","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The COVID-19 pandemic exposed vulnerabilities in traditional disease surveillance systems, particularly in data reporting and contact tracing. Telemedicine emerged as a promising approach to expand remote access to healthcare. This study aimed to evaluate a newly implemented telemedicine system designed to manage patients with COVID-19, reduce hospital overload, enable early case detection and isolation, ensure rapid response to clinical deterioration, simplify medical records, and provide ongoing patient support.
Methods: A prospective cohort study was conducted using the E-care telemedicine system to assist adult patients presenting with COVID-19 symptoms at a Brazilian university between June 2021 and June 2024.
Results: The E-care system delivered care to 6,129 patients, predominantly female, white university students. Physicians attended over 80% (4,903/6,129) of patients and prescribed medications to nearly 28% (1,411/5,041). Medical certificates for time off work were issued to 43% (2,635/6,129) of participants. COVID-19 tests were recommended for approximately 24% of patients, with a positivity rate above 81% among those who returned results. Only 66 patients (1.2%) required in-person care, and no COVID-19-related deaths were reported. Patient satisfaction was high, with 96% (5,584/6,129) expressing satisfaction or high satisfaction with the service.
Conclusions: This study provides robust evidence supporting the successful implementation of a telemedicine system for managing COVID-19 cases. The large number of users highlights an unmet demand for virtual healthcare. Telemedicine was rapidly adopted, achieved high patient satisfaction, and contributed to reducing hospital burden, promoting early detection, and minimizing in-person consultations. These findings reinforce the value of telemedicine as an essential tool for health systems and policymakers to strengthen care delivery beyond the pandemic.
期刊介绍:
Journal of Venomous Animals and Toxins including Tropical Diseases (JVATiTD) is a non-commercial academic open access publication dedicated to research on all aspects of toxinology, venomous animals and tropical diseases. Its interdisciplinary content includes original scientific articles covering research on toxins derived from animals, plants and microorganisms. Topics of interest include, but are not limited to:systematics and morphology of venomous animals;physiology, biochemistry, pharmacology and immunology of toxins;epidemiology, clinical aspects and treatment of envenoming by different animals, plants and microorganisms;development and evaluation of antivenoms and toxin-derivative products;epidemiology, clinical aspects and treatment of tropical diseases (caused by virus, bacteria, algae, fungi and parasites) including the neglected tropical diseases (NTDs) defined by the World Health Organization.